| | | | | |
| €27,3103 | +0,27% | €240,56M | €15,84K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | €12,0579 | -0,21% | €240,27M | €40,09K | |
TSI TCW Strategic Income Fund, Inc. | €3,7563 | +0,46% | €239,87M | €219,32K | |
PAII Pyrophyte Acquisition Corp. II | €8,8033 | +0,05% | €239,45M | €15,53K | |
| €12,0321 | -4,10% | €239,33M | €335,67K | |
YDES YD Bio Limited Ordinary Shares | €3,9878 | -0,85% | €239,33M | €15,05K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,5674 | +0,00% | €239,02M | €24,01 | |
RWAY Runway Growth Finance Corp. Common Stock | €5,6344 | -1,05% | €239,01M | €332,09K | |
JILL J.Jill, Inc. Common Stock | €17,1606 | -0,99% | €239,00M | €29,69K | |
LCTX Lineage Cell Therapeutics, Inc. | €0,93478 | +0,93% | €238,58M | €494,70K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8,8461 | +0,05% | €238,51M | €12,55K | |
ACV Virtus Diversified Income & Convertible Fund | €22,6921 | -0,71% | €238,49M | €8,43K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,7023 | -2,70% | €238,35M | €208,59K | |
| €1,2006 | -2,10% | €238,27M | €650,15K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | €2,5728 | +0,00% | €238,12M | €43,06K | |
